BI 135585 XX
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BI 135585 XX, covering 2013-03-07 to 2014-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes [Phase 1]